This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MercadoLibre (MELI) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
MercadoLibre (MELI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
McDonald's (MCD) Gains From Innovation & Expansion Efforts
by Zacks Equity Research
Menu innovation, digitalization, loyalty program and expansion efforts aid McDonald's (MCD).
MercadoLibre (MELI) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
MercadoLibre (MELI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Has MercadoLibre (MELI) Outpaced Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Here is how MercadoLibre (MELI) and Tecnoglass (TGLS) have performed compared to their sector so far this year.
Is Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QQQE
MercadoLibre (MELI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
MercadoLibre (MELI) closed at $1,070 in the latest trading session, marking a -1.19% move from the prior day.
If You Invested $1000 in MercadoLibre a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
The 3 Biggest Surprises so Far in 2023
by Andrew Rocco
The first few weeks of 2023 have been action packed and surprising in many ways. Today, Andrew Rocco dives into the three most shocking stories thus far.
MercadoLibre (MELI) Soars 5.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
MercadoLibre (MELI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
5 Stocks Powering Nasdaq ETF to Start 2023
by Sweta Killa
The rally has been broad-based. And the high beta and high growth sector took charge, with the tech-heavy Nasdaq Composite Index rising 5.1% in the initial two weeks of 2023.
Stock Market News for Jan 13, 2023
by Zacks Equity Research
U.S. stock markets closed higher on Thursday following a favorable inflation data of December.
Here is What to Know Beyond Why MercadoLibre, Inc. (MELI) is a Trending Stock
by Zacks Equity Research
MercadoLibre (MELI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
MercadoLibre (MELI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, MercadoLibre (MELI) closed at $837.44, marking a +1.37% move from the previous day.
Is Trending Stock MercadoLibre, Inc. (MELI) a Buy Now?
by Zacks Equity Research
MercadoLibre (MELI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Vamos Argentina! Too Late to Bet on World Cup Champs?
by Andrew Rocco
Argentina's stock market has been drastically outperforming global markets in recent months. Can the strength continue?
Should Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for QQQE
MercadoLibre, Inc. (MELI) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
MercadoLibre (MELI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is First Trust NASDAQ100 Equal Weighted ETF (QQEW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QQEW
The Zacks Analyst Blog Highlights Lowe's, Gilead Sciences, Intuitive Surgical, Valero Energy and MercadoLibre
by Zacks Equity Research
Lowe's, Gilead Sciences, Intuitive Surgical, Valero Energy and MercadoLibre are part of the Zacks top Analyst Blog.
Top Analyst Reports for Lowe's, Gilead Sciences & Intuitive Surgical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Lowe's Companies, Inc. (LOW), Gilead Sciences, Inc. (GILD) and Intuitive Surgical, Inc. (ISRG).
Should First Trust NASDAQ100 Equal Weighted ETF (QQEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for QQEW
Is Direxion NASDAQ100 Equal Weighted Index Shares (QQQE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QQQE
MercadoLibre (MELI) Q3 Earnings Beat Mark, Revenues Rise Y/Y
by Zacks Equity Research
MercadoLibre's (MELI) third-quarter results reflect strong performances by Mercado Pago, Mercado Envios and Mercado Credito.
MercadoLibre (MELI) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
MercadoLibre (MELI) delivered earnings and revenue surprises of 10.82% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
MercadoLibre (MELI) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
MercadoLibre's (MELI) third-quarter results are expected to reflect benefits from its fintech, e-commerce and logistics businesses.